In this episode of the Nico Misleh Podcast, Nico lays out a clear, practical perspective for clinic owners worried about the GLP-1 storm and recent initiatives like TrumpRx. He stresses that while GLP-1 medications are powerful and disruptive, they were never going to stay ultra-expensive forever. That shift toward lower prices and commoditization is normal. The business question is how clinics respond.
Two Reliable Playbooks: Value or Volume
Nico describes two realistic responses when a high-margin treatment becomes cheaper. One approach is to double down on value. Create a high-touch, concierge-style program where the prescription is only one part of the offering. Patients pay for coaching, metabolic monitoring, muscle preservation strategies, personalized compounding, and ongoing lab work. This protects prices because the clinic delivers more than a prescription.
The second approach is volume. If margins compress, accept the lower price and see more patients. That requires systems, staffing, and patient flow that scale without collapsing quality. Either strategy works, but a clinic should pick one and execute.
Build A Moat: Diversify Around Durable Services
Nico recommends anchoring a practice with services that are rock solid and not easily disrupted. He highlights HRT (hormone replacement therapy) as an ideal backbone. HRT is widely used, evidence-based, and unlikely to be removed by market shifts. Offering HRT alongside functional primary care, performance medicine, or aesthetics creates a protective moat so a single regulatory or pricing change won’t sink the business.
He also points out that commoditized products like testosterone can still generate stable revenue if packaged inside a broader service model. Charging $200 a month for a program that includes labs, coaching, and follow-up is reasonable, even if the medication itself only costs a few dozen dollars.
Practical Tactics Clinic Owners Can Use Now
- Audit revenue concentration: know what percentage of income comes from any single product or service.
- Design modular offerings: convert transactional prescriptions into programs with measurable outcomes and recurring fees.
- Invest in resilient services: HRT, primary care, and certain aesthetic procedures are lower risk and durable.
- Have a pivot plan: if GLP-1 prescribing changes overnight, be prepared to shift marketing and staffing quickly.
Mindset: Stay Creative, Stay Calm
Nico emphasizes that panic is the wrong response. Business owners in healthcare have options and creativity. Even if a revenue stream gets trimmed, a well-designed clinic can pivot. He warns against lifestyle inflation tied to volatile income and recommends treating high-risk earnings differently from stable ones.
Want More Insights On How To Level Up Your Clinic’s Service & Impact?
For daily insights, tips, and clinic-level thinking from Nico, sign up for the FREE Daily Newsletter! Yes, it arrives every weekday, and many clinicians stay subscribed because it’s straight talk and actionable ideas.
FAQ
Q: If GLP-1 costs drop dramatically, does that mean no clinic can profit from them?
A: Not necessarily. Profitability will shift toward clinics that either add substantial non-pharmaceutical value or scale patient volume efficiently. Writing a prescription alone becomes low margin; combining medication with monitoring, coaching, and specialized dosing preserves revenue.
Q: Why is HRT a safer foundation than weight-loss drugs?
A: HRT is established, widely needed, and supported by longstanding clinical evidence. It is less vulnerable to sudden market entry, price wars, or pharmacy policy shifts. That makes it a resilient service to anchor a practice.
Q: What should a clinic do first to prepare for market shifts?A: Start by analyzing revenue concentration, then create one new program that adds measurable value beyond a prescription. Document workflows so you can scale either value-based or volume-based models quickly.
